Gene · 2249
Papers3,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Growth factor applications and clinical translation: advances and challenges. | Ann Med | 2026 | 41837883 | PubTator, text mining | PubMed |
| Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies. | Signal Transduct Target Ther | 2026 | 41786685 | PubTator, text mining | PubMed |
| Clustering-based progressive alignment with fuzzy logic (CPA-FL). | Biochem Biophys Rep | 2026 | 41783109 | PubTator, text mining | PubMed |
| Broadening horizons: new links between cilia and heart development and disease. | Front Cardiovasc Med | 2026 | 41783016 | PubTator, text mining | PubMed |
| Personalized pharmacokinetic-pharmacodynamic guided therapy via an induced pluripotent stem cell-derived multi-organoid platform in NF1-mutant breast cancer. | Signal Transduct Target Ther | 2026 | 41781386 | PubTator, text mining | PubMed |
| Nasopharyngeal Carcinoma at the Virology Precision Oncology Nexus: Decoding Molecular Alterations for Early Intervention and Therapeutic Innovation. | Biomolecules | 2026 | 41750326 | PubTator, text mining | PubMed |
| Fibroblast-Derived ECM as a Donor-Specific Pro-Osteogenic Coating Surpassing ASC- and Osteoblast-Derived ECM. | J Funct Biomater | 2026 | 41745559 | PubTator, text mining | PubMed |
| Assessing the Impact of Comprehensive Genomic Profiling on Therapeutic Selection for Advanced Solid Tumors in Portugal. | Curr Oncol | 2026 | 41744832 | PubTator, text mining | PubMed |
| Somatic structural variants drive upper tract urothelial carcinoma muscle invasiveness via activation of TPX2 transcription. | EBioMedicine | 2026 | 41740229 | PubTator, text mining | PubMed |
| A cell atlas of multiple liver organoids and the fetal liver based on scRNA-seq. | iScience | 2026 | 41736863 | PubTator, text mining | PubMed |
| Glycosaminoglycan-functionalized hydrogels for sustained delivery of tissue inhibitor of metalloproteinase-3 mediating matrix metalloprotease inhibition and extracellular matrix stabilization. | Bioact Mater | 2026 | 41732672 | PubTator, text mining | PubMed |
| FGF4 activates FGFR1 - PI3K/AKT signaling to enhance Clec10a-mediated intracellular myelin debris processing and promote spinal cord repair. | J Neuroinflammation | 2026 | 41724991 | PubTator, text mining | PubMed |
| Biomarker discovery and drug repurposing in hepatocellular carcinoma through transcriptomics, machine learning, network pharmacology, and molecular dynamics. | Comput Biol Chem | 2026 | 41671946 | PubTator, text mining | PubMed |
| Distinct roles for SETα and SETβ in early cell fate decisions. | Nucleic Acids Res | 2026 | 41665009 | PubTator, text mining | PubMed |
| Conversational AI-Enabled Precision Oncology Reveals Context-Dependent MAPK Pathway Alterations in Hispanic/Latino and Non-Hispanic White Colorectal Cancer Stratified by Age and FOLFOX Exposure. | Cancers (Basel) | 2026 | 41595212 | PubTator, text mining | PubMed |
| IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanisms. | Neurooncol Adv | 2026 | 41568176 | PubTator, text mining | PubMed |
| Mutational patterns and ancestry-linked profiles in a large hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma cohort. | ESMO Open | 2026 | 41564818 | PubTator, text mining | PubMed |
| Characterization of ESR1 alterations in patients with breast and gynecologic cancers. | Breast Cancer Res | 2026 | 41555446 | PubTator, text mining | PubMed |
| A novel oncogenic nonsense mutation of SMARCA4 and genetic characteristic analysis of SMARCA4 (BRG1)-deficient undifferentiated tumor of the bladder. | Virchows Arch | 2026 | 41555058 | PubTator, text mining | PubMed |
| Endogenous FGFs drive ERK-dependent cell fate patterning in 2D human gastruloids. | Development | 2026 | 41521789 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2249/papers?page=2